Clinical trial · Observational
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Multicenter Comparative Study Between Thymomatous and Non-Thymomatous Patients
NCT07319689CI-TRIAL-00100202completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to assess and compare predictors of outcome in patients with thymomatous and non-thymomatous MG undergoing Thoracoscopic thymectomy.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myasthenia Gravis | — | UNRESOLVED | — |
| Non-Thymomatous | — | UNRESOLVED | — |
| Predictor | — | UNRESOLVED | — |
| Thoracoscopic Thymectomy | — | UNRESOLVED | — |
| Thymomatous | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Thymomatous Myasthenia Gravis group
- description
- Thymomatous myasthenia gravis (patients with histologically confirmed thymoma).
- interventionNames
- Other: Data collection
- label
- Non-thymomatous Myasthenia Gravis group
- description
- Non-thymomatous myasthenia gravis (patients with thymic hyperplasia or normal/ involuted thymus).
- interventionNames
- Other: Data collection
Primary outcomes (1)
- measure
- Proportion of patients achieving complete stable remission
- timeFrame
- 12 months post-procedure
- description
- Proportion of patients achieving complete stable remission was recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Both sexes. * Confirmed diagnosis of Myasthenia Gravis (MG). * Underwent Thoracoscopic thymectomy. * Availability of complete preoperative and postoperative records, including imaging and histopathology. * Minimum follow-up of 9 months post-surgery. Exclusion Criteria: * Patients who underwent thymectomy for indications other than MG. * Incomplete medical records or loss to follow-up before outcome assessment. * Patients with concomitant neuromuscular disorders other than MG
References
Publications (0)
Data not yet available
No reference posted for this study.